Press releases
- Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
- Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
- Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
- Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
- Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
- Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
- Twist Bioscience to Present at Upcoming Investor Conferences
- Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
- Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
More ▼
Key statistics
On Friday, Twist Bioscience Corp (0ME:DUS) closed at 52.82, -3.08% below its 52-week high of 54.50, set on Jul 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 52.32 |
---|---|
High | 53.34 |
Low | 52.32 |
Bid | 52.34 |
Offer | 54.04 |
Previous close | 54.50 |
Average volume | 43.40 |
---|---|
Shares outstanding | 58.23m |
Free float | 57.22m |
P/E (TTM) | -- |
Market cap | 3.38bn USD |
EPS (TTM) | -3.35 USD |
Data delayed at least 15 minutes, as of Jul 26 2024 18:30 BST.
More ▼